Depot medroxyprogesterone - Management of side-effects commonly associated with its contraceptive use

被引:12
|
作者
Archer, B
Irwin, D
Jensen, K
Johnson, ME
Rorie, J
机构
[1] UNIV CALIF SAN DIEGO, SAN DIEGO, CA 92103 USA
[2] UNIV FLORIDA, MED CTR, MIDWIFERY SERV, JACKSONVILLE, FL 32209 USA
[3] ROSEBERG WOMENS HLTH CARE, ROSEBURG, OR USA
[4] OB GYN HLTH CARE, VESTAL, NY USA
[5] DIMOCK COMMUNITY HLTH CTR, BOSTON, MA USA
[6] BOSTON UNIV, SCH PUBL HLTH, BOSTON, MA USA
来源
JOURNAL OF NURSE-MIDWIFERY | 1997年 / 42卷 / 02期
关键词
D O I
10.1016/S0091-2182(96)00135-8
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Depot medroxyprogesterone acetate is one of the most popular, effective methods of contraception used in the United States. Many women experience unpleasant side effects from this method, including episodic vaginal bleeding, hair loss, depression, and weight gain. This Clinical Practice Exchange describes the treatment strategies for these side-effects used by nurse-midwives from a variety of settings and locales. Contraceptive use can be more acceptable for many women if they are better able to cope with unpleasant side effects of the method. This Clinical Practice Exchange provides knowledge to enhance client coping. (C) 1997 by the American College of Nurse-Midwives.
引用
收藏
页码:104 / 111
页数:8
相关论文
共 50 条
  • [1] Depot medroxyprogesterone: Management of side effects commonly associated with its contraceptive use (vol 42, pg 104, 1997)
    Ascher, B
    JOURNAL OF NURSE-MIDWIFERY, 1997, 42 (04): : 294 - 294
  • [2] THE CONTRACEPTIVE USE OF DEPOT MEDROXYPROGESTERONE ACETATE
    HICKEY, M
    FRASER, I
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1995, 38 (04): : 849 - 858
  • [3] Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity
    Zalenskaya, Irina A.
    Chandra, Neelima
    Yousefieh, Nazita
    Fang, Xi
    Adedipe, Oluwatosin E.
    Jackson, Suzanne S.
    Anderson, Sharon M.
    Mauck, Christine K.
    Schwartz, Jill L.
    Thurman, Andrea R.
    Doncel, Gustavo F.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (10): : 4622 - 4638
  • [4] SIDE-EFFECTS OF DEPOT FLUPHENAZINES
    AYD, FJ
    COMPREHENSIVE PSYCHIATRY, 1974, 15 (04) : 277 - 284
  • [5] Depot risperidone, hyperprolactinaemia and prolactin-associated side-effects
    McIlhinney, Selwyn
    Smith, Michael
    PSYCHIATRIC BULLETIN, 2008, 32 (09): : 358 - 359
  • [6] DEPOT NEUROLEPTICS - SIDE-EFFECTS AND SAFETY
    MARDER, SR
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1986, 6 (01) : S24 - S29
  • [7] NOMIFENSINE FOR SIDE-EFFECTS OF DEPOT NEUROLEPTICS
    HANKS, GW
    BRITISH JOURNAL OF PSYCHIATRY, 1982, 141 (JUL) : 101 - 101
  • [8] Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant
    Holman, R
    Stephen, G
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2005, 31 (04): : 333 - 334
  • [10] MEDROXYPROGESTERONE ACETATE ADMINISTERED INTRAMUSCULARLY EVERY THIRD MONTH AS A CONTRACEPTIVE - INVESTIGATION OF EFFICACY, SIDE-EFFECTS AND ACCEPTABILITY
    MARKER, IL
    DANISH MEDICAL BULLETIN, 1973, 20 (02): : R10 - R10